BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, offering promising breakthroughs across numerous health-related and industrial apps. With its structural similarity to The natural way derived human serum albumin, OsrHSA provides a safer, much more dependable substitute for therape